1. Home
  2. ICUI vs PCH Comparison

ICUI vs PCH Comparison

Compare ICUI & PCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • PCH
  • Stock Information
  • Founded
  • ICUI 1984
  • PCH 1903
  • Country
  • ICUI United States
  • PCH United States
  • Employees
  • ICUI N/A
  • PCH N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • PCH Real Estate Investment Trusts
  • Sector
  • ICUI Health Care
  • PCH Real Estate
  • Exchange
  • ICUI Nasdaq
  • PCH Nasdaq
  • Market Cap
  • ICUI 3.0B
  • PCH 3.3B
  • IPO Year
  • ICUI 1992
  • PCH N/A
  • Fundamental
  • Price
  • ICUI $129.10
  • PCH $40.39
  • Analyst Decision
  • ICUI Buy
  • PCH Strong Buy
  • Analyst Count
  • ICUI 6
  • PCH 6
  • Target Price
  • ICUI $186.60
  • PCH $49.67
  • AVG Volume (30 Days)
  • ICUI 269.3K
  • PCH 459.3K
  • Earning Date
  • ICUI 11-11-2025
  • PCH 10-27-2025
  • Dividend Yield
  • ICUI N/A
  • PCH 4.46%
  • EPS Growth
  • ICUI N/A
  • PCH 15.06
  • EPS
  • ICUI N/A
  • PCH 0.53
  • Revenue
  • ICUI $2,372,504,000.00
  • PCH $1,056,523,000.00
  • Revenue This Year
  • ICUI N/A
  • PCH $4.42
  • Revenue Next Year
  • ICUI N/A
  • PCH $3.61
  • P/E Ratio
  • ICUI N/A
  • PCH $76.19
  • Revenue Growth
  • ICUI 2.96
  • PCH N/A
  • 52 Week Low
  • ICUI $107.00
  • PCH $36.82
  • 52 Week High
  • ICUI $196.26
  • PCH $48.12
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 51.94
  • PCH 41.93
  • Support Level
  • ICUI $121.61
  • PCH $41.22
  • Resistance Level
  • ICUI $136.61
  • PCH $42.79
  • Average True Range (ATR)
  • ICUI 4.03
  • PCH 1.00
  • MACD
  • ICUI 0.24
  • PCH -0.23
  • Stochastic Oscillator
  • ICUI 49.93
  • PCH 3.88

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About PCH PotlatchDeltic Corporation

PotlatchDeltic Corp is a REIT that owns and manages forestland in Alabama, Arkansas, Idaho, Minnesota, and Mississippi. Potlach operates in three segments. The timberlands segment covers the planting and harvesting of trees, as well as the construction and maintenance of roads. The wood products segment manufactures and distributes lumber, plywood, and other wood products. The real estate segment covers the sales generated from company-owned timberlands, as well as commercial and residential properties. The timberlands and the wood product segments combined drive the majority of the company's revenue.

Share on Social Networks: